Cargando…

The Effect of the Frequently Used Cinacalcet for pHPT during the COVID-19 Pandemic on Perioperative Decrease in Parathyroid Hormone

Background: Cinacalcet is a calcimimetic drug that has increasingly been used as a bridging therapy for primary hyperparathyroidism (pHPT), especially during the COVID-19 pandemic. The aim of our study was to investigate if preoperative cinacalcet therapy affects intraoperative parathyroid hormone (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Radulova-Mauersberger, Olga, Keßler, Julia, Keßler, Ulrich, Stange, Katrin, Korn, Sandra, Weitz, Jürgen, Bork, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000147/ https://www.ncbi.nlm.nih.gov/pubmed/35407623 http://dx.doi.org/10.3390/jcm11072015

Ejemplares similares

Questionable value of [(99m)Tc]-sestamibi scintigraphy in patients with pHPT and negative ultrasound
por: Lenschow, Christina, et al.
Publicado: (2022)

Vascular surgery in liver resection
por: Radulova-Mauersberger, Olga, et al.
Publicado: (2021)

Risk-factors for nodular hyperplasia of parathyroid glands in sHPT patients
por: Jäger, Mark D., et al.
Publicado: (2017)

Rapid Decrease of Intact Parathyroid Hormone Could Be a Predictor of Better Response to Cinacalcet in Hemodialysis Patients
por: Kim, Jwa-Kyung, et al.
Publicado: (2013)

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
por: Di Dalmazi, Giulia, et al.
Publicado: (2018)

Intact parathyroid hormone and whole parathyroid hormone assay results disagree in hemodialysis patients under cinacalcet hydrochloride therapy
por: Koda, Ryo, et al.
Publicado: (2014)

SAT-369 Parathyroid Microadenomas as a Cause of Normocalcemic Primary Hyperparathyroidism (PHPT) and a Surgical Challenge
por: Nguyen, Tiffany, et al.
Publicado: (2020)

COMPASS: deCOMPressing stomA and two-Stage elective resection vs. emergency reSection in patients with left-sided obstructive colon cancer
por: Pecqueux, Mathieu, et al.
Publicado: (2023)

Correction: COMPASS: deCOMPressing stomA and two-Stage elective resection vs. emergency reSection in patients with left-sided obstructive colon cancer
por: Pecqueux, Mathieu, et al.
Publicado: (2023)

Rescue of High Glucose Impairment of Cultured Human Osteoblasts Using Cinacalcet and Parathyroid Hormone
por: Shahen, V. A., et al.
Publicado: (2023)

Identification of 4 New Loci Associated With Primary Hyperparathyroidism (PHPT) and a Polygenic Risk Score for PHPT
por: Soto-Pedre, Enrique, et al.
Publicado: (2022)

How we do it—the use of peritoneal patches for reconstruction of vena cava inferior and portal vein in hepatopancreatobiliary surgery
por: Radulova-Mauersberger, O., et al.
Publicado: (2022)

Hypertension Secondary to PHPT: Cause or Coincidence?
por: Schiffl, Helmut, et al.
Publicado: (2011)

Concomitant occurrence of primary hyperparathyroidism (PHPT) due to mediastinal parathyroid adenoma and sublingual thyroid gland: the role of parathyroid technetium‐99m‐MIBI scintigraphy
por: Choukry, Sara, et al.
Publicado: (2017)

The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma
por: Nadarasa, K, et al.
Publicado: (2014)

Cinacalcet for Hypercalcemia Caused by Pulmonary Squamous Cell Carcinoma Producing Parathyroid Hormone-Related Peptide
por: Bech, Anneke, et al.
Publicado: (2012)

Analysis of predictors for postoperative complications after pancreatectomy––what is new after establishing the definition of postpancreatectomy acute pancreatitis (PPAP)?
por: Radulova-Mauersberger, O., et al.
Publicado: (2023)

Drainless robot-assisted minimally invasive oesophagectomy—randomized controlled trial (RESPECT)
por: Müssle, B., et al.
Publicado: (2023)

Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features
por: Gill, Anthony J., et al.
Publicado: (2019)

Successful use of cinacalcet to treat parathyroid-related hypercalcemia in two pediatric patients
por: Mogas, E, et al.
Publicado: (2018)

Case report of a cystic parathyroidal adenoma with rapid growth induced by cinacalcet
por: Werner, Christoph, et al.
Publicado: (2020)

SAT-349 Cinacalcet Resistant Tertiary Hyperparathyroidism with One Large Parathyroid Gland
por: Chaker, Bayan, et al.
Publicado: (2020)

Selective Decontamination of the Digestive Tract in Pancreatic Head Resections—A Propensity Score-Matched Analysis
por: Radulova-Mauersberger, Olga, et al.
Publicado: (2022)

SAT182 Effects Of An Orally Bioavailable Nonpeptide Parathyroid Hormone Receptor Type 1 (PTH1R) Antagonist In Rodent Models Of Primary Hyperparathyroidism (PHPT)
por: Antwan, Agnes S, et al.
Publicado: (2023)

Effect of HPT and accumulative HPT on structure formation and microhardness of the novel Ti18Zr15Nb alloy
por: Gunderov, D., et al.
Publicado: (2021)

Successful cinacalcet treatment of refractory secondary hyperparathyroidism due to multiple lung parathyroid adenomas
por: Sugi, Orie, et al.
Publicado: (2010)

Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD
por: Miller, Gerald, et al.
Publicado: (2012)

The administration of cinacalcet hydrochloride just before a haemodialysis session suppresses the transient rise in intact parathyroid hormone induced by a low-calcium dialysate: when should cinacalcet hydrochloride be administered?
por: Date, Toshiyuki, et al.
Publicado: (2008)

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction
por: Zitt, Emanuel, et al.
Publicado: (2013)

Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study
por: St. Peter, Wendy L, et al.
Publicado: (2015)

Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism
por: Meola, Mario, et al.
Publicado: (2009)

Association Between Resistance to Cinacalcet and Parathyroid Gland Hyperplasia in Kidney Transplant Recipients with Persistent Hypercalcemia
por: Oruc, A., et al.
Publicado: (2020)

Mechanistic analysis for time-dependent effects of cinacalcet on serum calcium, phosphorus, and parathyroid hormone levels in 5/6 nephrectomized rats
por: Wu-Wong, J Ruth, et al.
Publicado: (2013)

Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients
por: Zheng, Cai-Mei, et al.
Publicado: (2018)

Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism
por: Tanaka, Motoko, et al.
Publicado: (2008)

The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case report
por: Takada, Daisuke, et al.
Publicado: (2017)

Cinacalcet is effective in the treatment of hyperparathyroidism secondary to malignant transformation of autotransplanted parathyroid tissue. A case report
por: Dattolo, Pietro, et al.
Publicado: (2010)

Immunohistochemical localization of phosphohistidine phosphatase PHPT1 in mouse and human tissues
por: Zhang, Xiau-Qun, et al.
Publicado: (2009)

Structural and activity characterization of human PHPT1 after oxidative modification
por: Martin, Daniel R., et al.
Publicado: (2016)

“Primary Hyperparathyroidism (PHPT) in Children: Two Case Reports and Review of the Literature”
por: Tuli, Gerdi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6e0ipdh2ri4f9o0ndgrrc3uaic